163 related articles for article (PubMed ID: 34116668)
1. CCDC114, DNAI2 and TOP2A involves in the effects of tibolone treatment on postmenopausal endometrium.
Lv Y; Liu Y; Wang Y; Kong F; Pang Q; Hu G
BMC Womens Health; 2021 Jun; 21(1):240. PubMed ID: 34116668
[TBL] [Abstract][Full Text] [Related]
2. Molecular analysis of human endometrium: short-term tibolone signaling differs significantly from estrogen and estrogen + progestagen signaling.
Hanifi-Moghaddam P; Boers-Sijmons B; Klaassens AH; van Wijk FH; den Bakker MA; Ott MC; Shipley GL; Verheul HA; Kloosterboer HJ; Burger CW; Blok LJ
J Mol Med (Berl); 2007 May; 85(5):471-80. PubMed ID: 17226044
[TBL] [Abstract][Full Text] [Related]
3. Apoptosis in the endometrium of postmenopausal women receiving tibolone.
Gökaslan H; Oktem O; Durmuşoglu F; Eren F
Gynecol Obstet Invest; 2003; 56(3):124-7. PubMed ID: 14504425
[TBL] [Abstract][Full Text] [Related]
4. Histological and immunohistochemical evaluation of postmenopausal endometrium after 3 weeks of treatment with tibolone, estrogen only, or estrogen plus progestagen.
Klaassens AH; van Wijk FH; Hanifi-Moghaddam P; Sijmons B; Ewing PC; Ten Kate-Booij MJ; Kooi GS; Kloosterboer HJ; Blok LJ; Burger CW
Fertil Steril; 2006 Aug; 86(2):352-61. PubMed ID: 16828477
[TBL] [Abstract][Full Text] [Related]
5. A comparative study of an estradiol-releasing vaginal ring versus tibolone in postmenopausal women: a transvaginal color Doppler study.
Botsis D; Kassanos D; Kalogirou D; Antoniou G; Karakitsos P; Zourlas PA
Maturitas; 1997 May; 27(1):77-83. PubMed ID: 9158081
[TBL] [Abstract][Full Text] [Related]
6. [The influence of a tibolone therapy on endometrium in postmenopausal women].
Szlendak-Sauer K; Wierzba W; Radowicki S
Ginekol Pol; 2008 Nov; 79(11):758-61. PubMed ID: 19140498
[TBL] [Abstract][Full Text] [Related]
7. Effects of low dose of tibolone on steroid receptors and Bcl-2 on the postmenopausal endometrium.
Reis BF; Lima SM; Silva GM; Francisco AM; Barbosa LC; Archangelo SC; Grande RM
Histol Histopathol; 2016 Jun; 31(6):629-34. PubMed ID: 26670665
[TBL] [Abstract][Full Text] [Related]
8. Tibolone histology of the endometrium and breast endpoints study: design of the trial and endometrial histology at baseline in postmenopausal women.
Archer DF; Hendrix S; Ferenczy A; Felix J; Gallagher JC; Rymer J; Skouby SO; den Hollander W; Stathopoulos V; Helmond FA;
Fertil Steril; 2007 Oct; 88(4):866-78. PubMed ID: 17548089
[TBL] [Abstract][Full Text] [Related]
9. Absent correlation between vaginal bleeding and oestradiol levels or endometrial morphology during tibolone use in early postmenopausal women.
Berning B; van Kuijk C; Bennink HJ; Fauser BC
Maturitas; 2000 Apr; 35(1):81-8. PubMed ID: 10802404
[TBL] [Abstract][Full Text] [Related]
10. Long term effects of tibolone on the genital tract in postmenopausal women.
Morris EP; Wilson PO; Robinson J; Rymer JM
Br J Obstet Gynaecol; 1999 Sep; 106(9):954-9. PubMed ID: 10492108
[TBL] [Abstract][Full Text] [Related]
11. Integrated bioinformatics analysis for the screening of hub genes and therapeutic drugs in ovarian cancer.
Yang D; He Y; Wu B; Deng Y; Wang N; Li M; Liu Y
J Ovarian Res; 2020 Jan; 13(1):10. PubMed ID: 31987036
[TBL] [Abstract][Full Text] [Related]
12. Transvaginal ultrasonographic assessment of the endometrium in asymptomatic, postmenopausal women using different HRT regimens containing tibolone or estrogen.
Kurtay G; Berker B; Demirel C
J Reprod Med; 2004 Nov; 49(11):893-8. PubMed ID: 15603100
[TBL] [Abstract][Full Text] [Related]
13. Bioinformatic identification of candidate biomarkers and related transcription factors in nasopharyngeal carcinoma.
Ye Z; Wang F; Yan F; Wang L; Li B; Liu T; Hu F; Jiang M; Li W; Fu Z
World J Surg Oncol; 2019 Apr; 17(1):60. PubMed ID: 30935420
[TBL] [Abstract][Full Text] [Related]
14. Molecular mechanisms underlying gliomas and glioblastoma pathogenesis revealed by bioinformatics analysis of microarray data.
Vastrad B; Vastrad C; Godavarthi A; Chandrashekar R
Med Oncol; 2017 Sep; 34(11):182. PubMed ID: 28952134
[TBL] [Abstract][Full Text] [Related]
15. Effects of tibolone on the endometrium.
Völker W; Coelingh Bennink HJ; Helmond FA
Climacteric; 2001 Sep; 4(3):203-8. PubMed ID: 11588943
[TBL] [Abstract][Full Text] [Related]
16. Integrated Bioinformatics Analysis for the Screening of Hub Genes and Therapeutic Drugs in Hepatocellular Carcinoma.
Su Q; Li W; Zhang X; Wu R; Zheng K; Zhou T; Dong Y; He Y; Wang D; Ran J
Curr Pharm Biotechnol; 2023; 24(8):1035-1058. PubMed ID: 35762549
[TBL] [Abstract][Full Text] [Related]
17. Pharmacokinetics of tibolone in early and late postmenopausal women.
Timmer CJ; Verheul HA; Doorstam DP
Br J Clin Pharmacol; 2002 Aug; 54(2):101-6. PubMed ID: 12207627
[TBL] [Abstract][Full Text] [Related]
18. Cause of vaginal bleeding in postmenopausal women taking tibolone.
Ginsburg J; Prelevic GM
Maturitas; 1996 May; 24(1-2):107-10. PubMed ID: 8794441
[TBL] [Abstract][Full Text] [Related]
19. The identification of key genes and pathways in hepatocellular carcinoma by bioinformatics analysis of high-throughput data.
Zhang C; Peng L; Zhang Y; Liu Z; Li W; Chen S; Li G
Med Oncol; 2017 Jun; 34(6):101. PubMed ID: 28432618
[TBL] [Abstract][Full Text] [Related]
20. A 5-year study on the effect of hormone therapy, tibolone and raloxifene on vaginal bleeding and endometrial thickness.
Christodoulakos GE; Botsis DS; Lambrinoudaki IV; Papagianni VD; Panoulis CP; Creatsa MG; Alexandrou AP; Augoulea AD; Dendrinos SG; Creatsas GC
Maturitas; 2006 Mar; 53(4):413-23. PubMed ID: 16140483
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
